Pakke med 10 hetteglass4 på lagerSpar 18 %Tesamorelin 10 mg
Stabilisert GHRH-analog
Tesamorelin GHRH analogue research peptide, Australian-shipped. Lab-verified ≥99% purity.
Kun til forskningsbruk. Denne forbindelsen selges strengt til in vitro-forskning og laboratorieformål og er ikke beregnet for menneskelig konsum eller terapeutisk bruk. Ved kjøp bekrefter du at du er en kvalifisert forsker og godtar vår fullstendige ansvarsfraskrivelse.
Bare 4 pakker igjen
Stabilisert analog av veksthormonfrigjørende hormon studert for virkninger på visceralt fettvev og IGF-1-akseaktivitet i forskningsmodeller.
Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.
Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanisme
Studert for selektiv binding til GHRH-reseptoren med forlenget halveringstid. Forskning knyttet til reduserte viscerale fettmarkører og forhøyet IGF-1 i studiepopulasjoner.
HPLC-verifisert mot en renhetsspesifikasjon på ≥99 %. Uavhengig testet av akkrediterte tredjepartslaboratorier.
Tesamorelin — vanlige spørsmål
What is Tesamorelin?
Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH). It is studied in growth-hormone research and pre-clinical models of metabolic regulation and body composition.
Is Tesamorelin legal in Australia?
Tesamorelin is not approved as a therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Tesamorelin for research use only.
What is the difference between Tesamorelin and CJC-1295?
Both are GHRH-analogue research peptides. CJC-1295 has a longer half-life and a stronger ability to extend the duration of GH pulses; Tesamorelin's modifications produce a shorter-acting but well-characterised GHRH-mimicking profile. They are studied as parallel research tools for different aspects of GHRH-pathway signalling.
What is the typical Tesamorelin research dosage?
Published clinical research (in the US, for the approved indication) has used 2 mg daily subcutaneous Tesamorelin. Research-protocol dosing varies by model. Human therapeutic dosing is not established in Australia.
Guider relatert til Tesamorelin
Forskere utforsker også
UtvalgtPakke med 10 hetteglassSpar 25 %Retatrutide
Lyofilisert pulver10 mg · 8 strengths
Tri-agonist GLP-1 / GIP / glukagon-forskningspeptid
I 1 stack
Pakke med 10 hetteglassSpar 22 %MOTS-c
Lyofilisert pulver10 mg · 2 strengths
Mitokondrielt avledet metabolsk peptid
I 2 stacker
Pakke med 10 hetteglassSpar 17 %5-Amino-1MQ
Lyofilisert pulver50 mg · 3 strengths
NNMT-hemmer, forskningsforbindelse